Area under the curve predictions of dalbavancin, a new lipoglycopeptide agent, using the end of intravenous infusion concentration data point by regression analyses such as linear, log-linear and power models-Reference-Cited by-同舟云学术

Area under the curve predictions of dalbavancin, a new lipoglycopeptide agent, using the end of intravenous infusion concentration data point by regression analyses such as linear, log-linear and power models

Published:2017-03-14 Issue:2 Volume:48 Page:148-156
ISSN:0049-8254
Container-title:Xenobiotica
language:en
Short-container-title:Xenobiotica

Author:

Bhamidipati Ravi Kanth¹,Syed Muzeeb²,Mullangi Ramesh¹,Srinivas Nuggehally³

Affiliation:

1. Drug Metabolism and Pharmacokinetics, Jubilant Biosys Ltd, Bangalore, Karnataka, India,

2. Department of Pharmaceutics, University of Florida, FL, USA, and

3. Suramus Bio, Drug Development, Bangalore, Karnataka, India

Publisher

Informa UK Limited

Subject

Health, Toxicology and Mutagenesis,Pharmacology,Toxicology,Biochemistry,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/00498254.2017.1294278

Reference25 articles.

1. In Vivo Pharmacodynamic Activity of the Glycopeptide Dalbavancin

2. Activity of dalbavancin, alone and in combination with rifampicin, against meticillin-resistant Staphylococcus aureus in a foreign-body infection model

3. Pharmacokinetics, Safety and Tolerability of Single Dose Dalbavancin in Children 12–17 Years of Age

4. Population Pharmacokinetic Analysis of Dalbavancin, a Novel Lipoglycopeptide

5. Human pharmacokinetics and rationale for once-weekly dosing of dalbavancin, a semi-synthetic glycopeptide

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Drug Monitoring of Dalbavancin in Real Life: A Two-Year Experience;Antibiotics;2023-12-24

2. Clinical Effectiveness and Pharmacokinetics of Dalbavancin in Treatment-Experienced Patients with Skin, Osteoarticular, or Vascular Infections;Pharmaceutics;2022-09-06

3. Therapeutic Drug Monitoring of Dalbavancin Treatment in Severe Necrotizing Fasciitis in 3 Critically Ill Patients: A Grand Round;Therapeutic Drug Monitoring;2020-04